Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for BOS prevention in lung transplant
NCT01009619Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Sep 2005
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in Bronchiolitis Obliterans Syndrome (BOS), sponsored by KU Leuven. Started Sep 2005; status: completed.
02
Drugs
azithromycin
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on NCT01009619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009619.